One Size Does Not Fit All: Personalized Immune Therapies Poised to Take Center Stage

By Azvolinsky Anna  

Journal of the National Cancer Institute, Vol. 105, Iss. 9, 2013-05 ,pp. : 583-584

Oxford University Press

Access to resources Recommend Favorite

Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: case report and review of the literature

By Lycette Jennifer   Luoh Shiuh-Wen   Beer Tomasz   Deloughery Thomas  

Breast Cancer Research and Treatment, Vol. 99, Iss. 3, 2006-10 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs)

By Oberguggenberger Anne  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 553-561

Springer Publishing Company

Access to resources Recommend Favorite

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

By Jonat Walter   Hilpert Felix   Maass Nicolai  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 32-38

Springer Publishing Company

Access to resources Recommend Favorite

Does Subjective Burden of Early Breast Cancer and its Treatment Affect Immune Measures During Adjuvant Therapy?

By Sabbioni Marzio E.E.   Bernhard Jürg   Siegrist Hans-Peter   Schmitz Shu-Fang Hsu   Gertsch Monica Castiglione   Thürlimann Beat   Bonnefoi Hervé   Perey Lucien   Herrmann Richard   Goldhirsch Aron   Hürny Christoph  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 75-86

Springer Publishing Company

Access to resources Recommend Favorite